PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers at Intermountain Medical Center develop new smartphone technology and app to diagnose and monitor adrenal gland diseases

Researchers at Intermountain Medical Center develop new smartphone technology and app to diagnose and monitor adrenal gland diseases
2014-06-24
(Press-News.org) Diseases of the adrenal gland have long been difficult to diagnose. But now, researchers have found an affordable and easy way to diagnose and monitor endocrine diseases of the adrenal gland by using saliva and a smartphone.

Researchers at Intermountain Medical Center in Murray, Utah, have developed new smartphone technology to help screen patients for a number of adrenal gland diseases, including Cushing's syndrome. The new tool also helps to identify adrenal insufficiency, monitor cortisol replacement and assess physiologic changes in adrenal function.

Adrenal diseases are commonly overlooked because measuring cortisol, the so-called "stress hormone" that is released by the adrenal glands as part of the fight-or-flight mechanism, is costly and complicated, especially for those with limited resources, say researchers.

"When cortisol levels are overlooked too many people suffer and die because of excess or insufficient cortisol," said Joel Ehrenkranz, MD, director of diabetes and endocrinology at Intermountain Medical Center, and lead researcher of the project.

To help solve this problem, researchers developed a simple saliva test that uses a smartphone and an attached device that inexpensively feeds the results of a saliva test into the smart phone. An app then quantifies and interprets the results of a salivary cortisol assay and gives results in five minutes at the point of care.

"The cortisol assay is similar in design to a home pregnancy test and urine sample drug tests," says Dr. Ehrenkranz. "It's like having an endocrine specialist in your phone."

Dr. Ehrenkranz and his team will present findings of this new smartphone technology at the 16th International Congress of Endocrinology on Tuesday, June 24, at 9:45 AM, CDT, in Chicago.

The idea for creating an easy and inexpensive test for cortisol first came to Dr. Ehrenkranz in 2007, while he was visiting Mulago Hospital in Kampala, Uganda. He was shown a 60-year-old woman suffering from Addison's disease, which occurs when the adrenal glands produce too little cortisol.

In order to help in the diagnosis, Dr. Ehrenkranz suggested testing the woman's cortisol levels, but her physicians resisted. Due to their current procedures, they felt the test would take too long and be too costly ($50) for the patient to afford. After drawing her blood, physicians would need to send the blood sample to a lab in Nairobi, Kenya, and by the time they received the results, the patient would likely have died.

"After my experience at Mulago, I knew I needed to develop a test and technology that would fix this problem of testing cortisol levels," said Dr. Ehrenkranz. "It needed to be inexpensive and easy to do."

The new technology will especially help diabetic patients.

For diabetics, controlling stress levels is key to controlling cortisol levels, which helps prevent and control the disease. Stress increases the levels of cortisol in their body, and elevations in cortisol impair the body's ability to metabolize glucose. This increases blood glucose levels. High cortisol levels also affect the body's ability to fight infections, lose weight and recovery from injury.

"What this means is when blood cortisol levels are too high, insulin will not lower blood sugar," said Dr. Ehrenkranz. "Elevations in cortisol decrease the effectiveness of insulin and other drugs used in the treatment of diabetes. Having the ability to easily and inexpensively measure cortisol levels is important in managing diabetes."

INFORMATION: Other researchers involved with the project include Theodore Espiritu, and Randall Polson PhD.

Intermountain Medical Center is the flagship medical facility for the Intermountain Healthcare system, based in Salt Lake City.


[Attachments] See images for this press release:
Researchers at Intermountain Medical Center develop new smartphone technology and app to diagnose and monitor adrenal gland diseases

ELSE PRESS RELEASES FROM THIS DATE:

To advance care for patients with brain metastases: Reject five myths

2014-06-24
New York, NY – A blue-ribbon team of national experts on brain cancer says that professional pessimism and out-of-date "myths," rather than current science, are guiding -- and compromising -- the care of patients with cancers that spread to the brain. In a special article published in the July issue of Neurosurgery, the team, led by an NYU Langone Medical Center neurosurgeon, argues that many past, key clinical trials were designed with out-of-date assumptions and the tendency of some physicians to "lump together" brain metastases of diverse kinds of cancer, often results ...

Mayo Clinic researchers say gene in brain linked to kidney cancer

2014-06-24
JACKSONVILLE, Fla. — A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting. Their study, published in Cancer Research, reveals that the gene NPTX2, plays an essential role in this cancer type, which is resistant to common chemotherapy and has a five-year overall survival rate of less than 10 percent in patients with metastatic disease. MULTIMEDIA ALERT: Video and audio are available for download on the Mayo Clinic ...

Virus kills triple negative breast cancer cells, tumor cells in mice

2014-06-24
A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer. Adeno-associated virus type 2 (AAV2) infects humans but is not known to cause sickness. In prior studies, the researchers tested the virus on a variety of breast cancers that represent degrees of aggressiveness and on human papillomavirus-positive cervical cancer cells. The virus initiated apoptosis -- ...

Morphable surfaces could cut air resistance

2014-06-24
CAMBRIDGE, Mass-- There is a story about how the modern golf ball, with its dimpled surface, came to be: In the mid-1800s, it is said, new golf balls were smooth, but became dimpled over time as impacts left permanent dents. Smooth new balls were typically used for tournament play, but in one match, a player ran short, had to use an old, dented one, and realized that he could drive this dimpled ball much further than a smooth one. Whether that story is true or not, testing over the years has proved that a golf ball's irregular surface really does dramatically increase ...

CNIO researcher Ana Losada revises the role of cohesin in cancer

2014-06-24
Massive sequencing of cancer genomes brings to light new genes every day that could be involved in the process of tumour formation. A good example of this is cohesin, a ring-shaped protein complex that embraces DNA to control cell division. Just a few months ago, and after several studies in the same direction, the sequencing of thousands of tumour samples identified the STAG2 gene—whose product forms part of cohesin—as one of the most frequently mutated genes in several types of cancer such as bladder cancer and melanoma. The challenge now is to understand the link between ...

Quick, easy, inexpensive cortisol testing should soon be available on all smartphones

2014-06-24
CHICAGO, IL—Researchers have developed a device that uses any smartphone to measure the cortisol concentration in saliva. The device was presented Tuesday, June 24, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago. "We have developed a method for measuring cortisol in saliva using a smartphone and a disposable test strip. This innovation enables anyone with a smartphone to measure their salivary cortisol level quickly, accurately, and affordably," said lead study author Joel R. L. Ehrenkranz, MD, director ...

Sweet sweet straw

Sweet sweet straw
2014-06-24
This news release is available in German. Erythritol has many great advantages: it does not make you fat, it does not cause tooth decay, it has no effect on the blood sugar and, unlike other sweeteners, it does not have a laxative effect. In Asia it is already widely used and it is becoming more and more common in other parts of the world too. Up until now, erythritol could only be produced with the help of special kinds of yeast in highly concentrated molasses. At the TU Vienna, a method has now been developed to produce the sweetener from ordinary straw with the help ...

Expert outlines challenges of visual accessibility for people with low vision

2014-06-24
June 24, 2014 – New approaches and tools are needed to improve visual accessibility for people with low vision in the "real world," according to a special article in the July issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Vision science, in collaboration with other professions, has a key role in developing technologies and design approaches to promote visual accessibility for the millions of people living with low vision, according ...

Experts cite 'misconceptions' on brain metastases

2014-06-24
June 24, 2014 – "Key historical misconceptions" are hindering progress in research and treatment for patients with cancer metastases to the brain, suggests a special article in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Dr. Douglas Kondziolka of NYU Langone Medical Center and coauthors identify some issues that may be standing in the way of optimal clinical management for patients with cancer that has spread to the brain from other ...

New transdermal SARM drug for muscle-wasting offers hope for older cancer patients

2014-06-24
CHICAGO, IL—Muscle wasting that occurs as a result of cancer negatively impacts the well-being and recovery prospects of millions of patients, particularly the rapidly-growing elderly populations in Western societies. Drugs called selective androgen receptor modulators (SARMs) offer hope for these patients, and a new SARM for transdermal administration is promising excellent efficacy without harming liver function and HDL levels. Results and conclusions were presented Tuesday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO ...

LAST 30 PRESS RELEASES:

$3 million NIH grant funds national study of Medicare Advantage’s benefit expansion into social supports

Amplified Sciences achieves CAP accreditation for cutting-edge diagnostic lab

Fred Hutch announces 12 recipients of the annual Harold M. Weintraub Graduate Student Award

Native forest litter helps rebuild soil life in post-mining landscapes

Mountain soils in arid regions may emit more greenhouse gas as climate shifts, new study finds

Pairing biochar with other soil amendments could unlock stronger gains in soil health

Why do we get a skip in our step when we’re happy? Thank dopamine

UC Irvine scientists uncover cellular mechanism behind muscle repair

Platform to map living brain noninvasively takes next big step

Stress-testing the Cascadia Subduction Zone reveals variability that could impact how earthquakes spread

We may be underestimating the true carbon cost of northern wildfires

Blood test predicts which bladder cancer patients may safely skip surgery

Kennesaw State's Vijay Anand honored as National Academy of Inventors Senior Member

Recovery from whaling reveals the role of age in Humpback reproduction 

Can the canny tick help prevent disease like MS and cancer?

Newcomer children show lower rates of emergency department use for non‑urgent conditions, study finds

Cognitive and neuropsychiatric function in former American football players

From trash to climate tech: rubber gloves find new life as carbon capturers materials

A step towards needed treatments for hantaviruses in new molecular map

Boys are more motivated, while girls are more compassionate?

Study identifies opposing roles for IL6 and IL6R in long-term mortality

AI accurately spots medical disorder from privacy-conscious hand images

Transient Pauli blocking for broadband ultrafast optical switching

Political polarization can spur CO2 emissions, stymie climate action

Researchers develop new strategy for improving inverted perovskite solar cells

Yes! The role of YAP and CTGF as potential therapeutic targets for preventing severe liver disease

Pancreatic cancer may begin hiding from the immune system earlier than we thought

Robotic wing inspired by nature delivers leap in underwater stability

A clinical reveals that aniridia causes a progressive loss of corneal sensitivity

Fossil amber reveals the secret lives of Cretaceous ants

[Press-News.org] Researchers at Intermountain Medical Center develop new smartphone technology and app to diagnose and monitor adrenal gland diseases